Delivery Order SPE2DB22D1202-SPE2DB25FUGL4

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XARELTO 20 MG TABLET 90S. The $5,192.68 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XARELTO 20 MG TABLET 90S. The contract has a ceiling value of $2,898.80 and an ultimate completion date of July 26, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xarelto 20 mg tablets. The contract has a ceiling value of $34,161.58 and an ultimate completion date of September 27, 2024. It is a delivery order contract with a firm fixed price pricing type. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of XARELTO 10 MG tablets. The $3,736.63 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of October 24, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, which serves as a...
This federal contract award, valued at $11,469.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Xarelto 20 mg tablets, a cardiovascular medication, with a completion date of September 22, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,657.74 firm fixed-price contract covers the delivery of XARELTO 20 MG TABLET 90S, a cardiovascular medication. The contract award has an ultimate completion date of October 25, 2024 and was issued on October 24, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XARELTO 20 MG TABLET 90S. The contract is a Delivery Order with a Firm Fixed Price of $9,734.53 and a completion date of August 8, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XARELTO 20 MG TABLET 90S, a medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,956.05 and a performance period that ends on February 4, 2025. The contract is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,697.97 firm fixed-price delivery order contract covers the supply of XARELTO 20 MG TABLET 90S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of November 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $13,146.65 with a firm fixed-price pricing type and an ultimate completion date of December 20, 2024. The contract provides for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUGL4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XARELTO 20 MG tablets. The contract has a ceiling value of $1,657.74 and a completion date of October 25, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award indicates open competition, as no set-aside designation was used.

Generated 1/23/25, 9:10 AM